Recombinant polypeptides having Ph1 p I epitope antigenicity...

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S069700, C530S300000, C530S324000, C530S325000, C530S326000, C530S327000, C530S402000

Reexamination Certificate

active

07148019

ABSTRACT:
A recombinant DNA molecule comprising a nucleotide sequence (I) which codes for a polypeptide displaying the antigenicity of one, two or more of the Phl p I epitope clones (28, 34, 41, 42, 43, 45, 50, 52, 64, 80, 85, 86, 95, 97, 98, 103, 108, 109, 113, 114), with the amino acid sequences defined in SEQ ID NOS: 5, 7, 9 and 12–28, and preferably being derived from grasses or monocotyledonic plants, or a nucleotide sequence (II) which hybridizes with such a nucleotide sequence (I) under conditions of high, stringency. Polypeptides displaying the antigenicity of one, two or more of the Phl p I epitope clones (28, 34, 41, 42, 43, 50, 52, 64, 80, 85, 86, 95, 97, 98, 103, 108, 109, 113, 114). Recombinant expression vectors containing the recombinant molecule and host cells transformed with the vector. Diagnostic methods based on utilizing the polypeptides in immunoassays for humoral antibodies and cellular reactions.

REFERENCES:
patent: 5710126 (1998-01-01), Griffith et al.
patent: 6300482 (2001-10-01), Ciossek et al.
patent: 6300487 (2001-10-01), Leung et al.
patent: 6303291 (2001-10-01), Friend et al.
patent: 6303302 (2001-10-01), Rupp et al.
patent: WO 9203550 (1992-03-01), None
patent: WO 9410314 (1994-05-01), None
patent: WO 9421675 (1994-09-01), None
Beers and Berkow. The Merck Manual of Diagnosis and Therapy. pp. 1042-1044. Seventeenth edition (1999).
Reeck et al. Cell, vol. 50, p. 667.
Valenta et al, “B-Cell Epitopes of Allergens determined by Recombinant Techniques; Use for Diagnosis and Therapy of Type I Allergy”,Arbeiten aus dem Paul Ehrlich Institute; Bundesamt für Sera und Impfstoffe, zu Frankfurt a.m., Jena, Stuttgart, DE, 1994, pp. 235-246.
Ball et al, “Isolation of an Immunodominant IgE Hapten from an Epitope Expression cDNA Library”,The Journal of Biological Chemistry, vol. 269, No. 45, Issue of Nov. 11, pp. 28823-28328, 1994.
Valenta et al, “Recombinant Allergens as Candidates for Immunotherapy of Type I Allergic Diseases”,Vaccines, 1993 Cold Spring Harbor Laboratory Press, pp. 37-42.
Friedhoff et al., J. Allergy Clin. Immunol. 78 (1986) 1190-1201.
Laffer et al., J. Allergy Clin. Immunol. 94 (1994) 689-698.
Laffer et al., J. Allergy Clin. Immunol. 94 (1994) 88-94.
Griffith et al., Fed. Eur. Biochem. Soc. 279 (1991) 210-215.
Perez et al., Journal of Biol. Chem. vol. 265, No. 27 (1990) 16210-16215.
George et al., Macromolecular Sequencing and Synthesis, Schlesinger, ed., Alan R. Liss Inc., New York, pp. 127-149 (1998).
Daniel et al., Virology 202:540-549 (1994).
Sambrook et al., Molecular Cloning, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, pp. 9.49-9.51 (1989).
Reeck et al, Cell 50:667 (1987).
Tian et al., 2001 Plant Molecular Biology 47:379-388.
Chai et al., 2001, Gene 274:27-33.
Cederberg et al., 2001, Cell 106:563-573.
Lewin, Science 237:1570 (1987).
Kusk et al, “Mapping of a New Immunodominant Human Linear B-cell Epitope on the vpu Protein of the Human Immunodeficiency Virus Type 1”,Journal of Acquired Immune Deficiency Syndromes, 6:334-338, 1993.
Valenta et al, “Diagnosis of Grass Pollen Allergy with Recombinant Timothy Grass (Phleum pretense) Pollen Allergens”,International Archives of Allergy and Immunology, 97:287-294, 1992.
Habets et al, “Mapping of B Cell Epitopes on Small Nuclear Ribonucleoproteins That React With Human Autoantibodies As Well As With Experimentally-Induced Mouse Monoclonal Antibodies”,The Journal of Immunology, vol. 143, 2560-2566, 1989.
Zhang et al “Mapping of Antibody Binding Epitopes of a Recombinant Poa IX Allergen”,Molecular Immunology, vol. 29, pp. 1383-1389, 1992.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Recombinant polypeptides having Ph1 p I epitope antigenicity... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Recombinant polypeptides having Ph1 p I epitope antigenicity..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant polypeptides having Ph1 p I epitope antigenicity... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3671269

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.